Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

CGNT vs CLBT: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

CLBT Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 6–4 Matrix Metrics)

CLBT Overall Winner 6-Pillar Tally: CGNT 2 – 4 CLBT Matrix Metrics: CGNT 4 – 6 CLBT

As of Nov 17, 2026, Cellebrite DI Ltd. Class A (CLBT) is the stronger overall head-to-head candidate over Cognyte Software Ltd. (CGNT) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CGNT carries a Unified Composite Score of 49.9/100 (HOLD) at $7.76 (22.0x Forward P/E, 4.1% operating margin), whereas CLBT carries 41.0/100 (SELL) at $10.73 (16.6x Forward P/E, 11.9% operating margin).

  • Composite vs. Pillar Nuance: While CGNT currently prints a higher short-term Unified Composite Score (49.9/100 HOLD vs. CLBT 41.0/100 SELL), CLBT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.9% vs. 4.1% operating margin) and revenue trajectory (+18.2% vs. +12.0% YoY).
  • Technical & Structure Timing Caution: CGNT is currently in a Breakdown options structure phase (RSI 37.1); meanwhile CLBT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 40.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About CGNT vs CLBT
CGNT NASDAQ
Cognyte Software Ltd. Ordinary Shares
Services-Prepackaged Software
$7.76
-3.48% 1D
Market Cap $608.5M
TTM Revenue $422M
Forward P/E 22.0x
Beta / 30D Vol 1.39β · 55% Vol
Unified Composite Score
49.9 / 100 HOLD
Tech 36.0 Fund 60.0 Flow 65.0 Mom 64.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 37
RSI-14: 37.1 · SMA20: $9.01 · SMA50: $8.74
CLBT NASDAQ Head-to-Head Winner
Cellebrite DI Ltd. Class A Ordinary Shares
Services-Prepackaged Software
$10.73
-3.46% 1D
Market Cap $2.9B
TTM Revenue $537M
Forward P/E 16.6x
Beta / 30D Vol 0.57β · 60% Vol
Unified Composite Score
41.0 / 100 SELL
Tech 25.0 Fund 46.0 Flow 58.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -0.2%), weak momentum, RSI 41
RSI-14: 40.6 · SMA20: $12.02 · SMA50: $11.59

6-Pillar Scorecard Institutional Category Breakdown (CGNT 2 – 4 CLBT)

Columns: Metric · CGNT · CLBT
1. Valuation Multiples CGNT
Forward P/E 22.0x 16.6x
Trailing P/E 10.3x 46.1x
PEG Ratio N/M N/M
EV / Revenue 1.3x 5.0x
2. Growth & Scale CLBT
Revenue Growth (YoY) +12.0% +18.2%
Earnings Growth (YoY) +177.7% +25.0%
TTM Revenue (USD) $422M $537M
Market Cap $608.5M $2.9B
3. Profitability & Quality CLBT
Gross Margin 73.0% 82.3%
Operating Margin 4.1% 11.9%
Net Profit Margin -0.0% 12.1%
Return on Equity (ROE) 2.2% 12.7%
4. Balance Sheet & Cash Flow CLBT
Cash Generation (TTM) $33M $142M
Cash Flow Margin 7.9% 26.4%
Net Cash / Leverage $67M Net Cash $200M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning CGNT
Options Structure Phase BREAKDOWN BREAKDOWN
Current IV / %ile 53.3% (56th %ile) 112.5% (39th %ile)
Put/Call OI Skew 0.07x (Call-Skewed) N/A
OBV Trend / Tech Phase DISTRIBUTION · Neutral NEUTRAL · Markdown
6. R&D & Supply-Chain Moat CLBT
OpEx & R&D Intensity 68.9% of Rev ($291M) 70.4% of Rev ($378M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Infrastructure Operator Software - Infrastructure Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: CGNT (4) vs CLBT (6)
Institutional Metric CGNT CLBT Criterion Row Edge
Market Capitalization
Scale
$608.5M $2.9B Larger Scale CLBT
Trailing P/E Ratio
Valuation
10.3x 46.1x Lower Multiple CGNT
Forward P/E Ratio
Valuation
22.0x 16.6x Lower Multiple CLBT
Revenue Growth (YoY)
Growth
+12.0% +18.2% Higher Growth CLBT
Operating Margin (TTM)
Profitability
4.1% 11.9% Higher Margin CLBT
Net Profit Margin
Profitability
-0.0% 12.1% Higher Margin CLBT
Return on Equity (ROE)
Capital Efficiency
2.2% 12.7% Higher ROE CLBT
52-Week Range Position
Momentum
24% ($6–$12) 12% ($10–$19) Stronger Trend CGNT
Beta / 30D Volatility
Risk Regime
1.39β · 55% Vol 0.57β · 60% Vol Lower Realized Risk CGNT
Unified Institutional Score
Composite Signal
49.9 / 100 (HOLD) 41.0 / 100 (SELL) Higher Composite CGNT
Trailing 12M Revenue (USD)
Operating Scale
$422M $537M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
73.0% 82.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · 1.3x EV/Rev N/M PEG · 5.0x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$33M ($67M Net Cash) $142M ($200M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CLBT +7.33 pp
CGNT: -11.01% · CLBT: -3.68%
3M Horizon CLBT +7.43 pp
CGNT: -11.92% · CLBT: -4.49%
6M Horizon CLBT +2.07 pp
CGNT: -22.32% · CLBT: -20.25%
1Y Horizon CGNT +33.44 pp
CGNT: -8.38% · CLBT: -41.82%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period CGNT Revenue CLBT Revenue CGNT Op. Margin CLBT Op. Margin Margin Leader
FY2019 $430M $170M 4.3% -0.9% CGNT
FY2020 $460M $190M 6.0% 4.7% CGNT
FY2021 $440M $250M 4.1% 5.6% CLBT
FY2022 $470M $270M 2.3% 0.4% CGNT
FY2023 $310M $330M -33.1% 10.2% CLBT
FY2024 $310M $400M -5.8% 14.2% CLBT
FY2025 $350M $480M -1.5% 14.0% CLBT
FY2026 $400M N/A 3.3% N/A CGNT

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
CGNT BREAKDOWN
117d in phase · OBV DISTRIBUTION
Current IV 53.3%
IV Percentile 56th %ile
Put/Call OI Skew 0.07x (Call-Skewed)
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BEARISH
OBV Flow DISTRIBUTION
Exact CGNT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CLBT BREAKDOWN
94d in phase · OBV NEUTRAL
Current IV 112.5%
IV Percentile 39th %ile
Put/Call OI Skew N/A
IV Regime Balanced (25th–60th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact CLBT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
CGNT Moat Profile Cyclical / Execution-Driven Positioning
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $608.5M market capitalization and 4.1% operating margin.
OpEx & R&D Reinvestment 68.9% of Rev ($291M)
90D Engineering Disclosures 0 Published
CLBT Moat Profile Cyclical / Execution-Driven Positioning
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $2.9B market capitalization and 11.9% operating margin.
OpEx & R&D Reinvestment 70.4% of Rev ($378M)
90D Engineering Disclosures 0 Published

Investor FAQ CGNT vs CLBT Key Questions & Quantitative Answers

As of Nov 17, 2026, Cellebrite DI Ltd. Class A (CLBT) is the stronger overall head-to-head candidate over Cognyte Software Ltd. (CGNT) in the Tradestie Institutional Equity Comparison Engine, winning 6–4 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Growth & Scale, Profitability & Quality, Balance Sheet & Cash Flow). CGNT carries a Unified Composite Score of 49.9/100 (HOLD) at $7.76 (22.0x Forward P/E, 4.1% operating margin), whereas CLBT carries 41.0/100 (SELL) at $10.73 (16.6x Forward P/E, 11.9% operating margin). Composite vs. Pillar Nuance: While CGNT currently prints a higher short-term Unified Composite Score (49.9/100 HOLD vs. CLBT 41.0/100 SELL), CLBT captures the overall institutional head-to-head verdict (6–4 matrix metrics and 4–2 across the 6 pillars) due to superior fundamental profitability (11.9% vs. 4.1% operating margin) and revenue trajectory (+18.2% vs. +12.0% YoY). Technical & Structure Timing Caution: CGNT is currently in a Breakdown options structure phase (RSI 37.1); meanwhile CLBT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 40.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

CLBT leads the Growth & Scale pillar: CGNT posts +12.0% YoY revenue growth and +177.7% YoY earnings growth on $422M TTM revenue (73.0% gross margin, 4.1% operating margin), compared with CLBT at +18.2% YoY revenue growth and +25.0% YoY earnings growth on $537M TTM revenue (82.3% gross margin, 11.9% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), CGNT cumulative revenue shifted -7.0% while CLBT shifted +182.4%. In operating R&D and SG&A reinvestment, CGNT deploys 68.9% of Rev ($291M) (0 90-day corporate R&D disclosures) versus 70.4% of Rev ($378M) (0 disclosures) for CLBT.

CGNT screens cheaper on headline valuation multiples. CGNT trades at 22.0x Forward P/E, 10.3x Trailing P/E, N/M PEG, and 1.3x EV/Revenue (7.9% FCF margin), whereas CLBT trades at 16.6x Forward P/E, 46.1x Trailing P/E, N/M PEG, and 5.0x EV/Revenue (26.4% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against CGNT (2.2% ROE) versus CLBT (12.7% ROE) capital efficiency.

In options market volatility and institutional positioning, CGNT carries 53.3% implied volatility (56th %ile, Balanced (25th–60th %ile)), a 0.07x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (1.39β · 55% Vol realized risk). By comparison, CLBT carries 112.5% implied volatility (39th %ile, Balanced (25th–60th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (0.57β · 60% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.